Have a personal or library account? Click to login
The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations Cover

The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations

Acta Pharmaceutica
Volume 73 (2023): Issue 4 (December 2023)
By: Vladimira Rimac,  Ines Bojanić,  Sanja Dabelić and  Branka Golubić Ćepulić  
Open Access
|Dec 2023

Authors

Vladimira Rimac

Department of Transfusion Medicine and Transplantation, Biology University Hospital Centre Zagreb, Zagreb, Croatia

Ines Bojanić

ines.bojanic@kbc-zagreb.hr

Department of Transfusion Medicine and Transplantation, Biology University Hospital Centre Zagreb, Zagreb, Croatia

Sanja Dabelić

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Branka Golubić Ćepulić

University of Zagreb School of Medicine, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2023-0037 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 655 - 672
Accepted on: Aug 25, 2023
Published on: Dec 26, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cryopreservation,
sample stability,
viability,
peripheral blood stem cells
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Vladimira Rimac, Ines Bojanić, Sanja Dabelić, Branka Golubić Ćepulić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 4 (December 2023)Next article